Loading stock…

LANXESS Aktiengesellschaft (LXS) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

LANXESS Aktiengesellschaft

LXSMarket cap $1.25BPrice $14.4

Country🇩🇪Germany

SectorMaterials

IndustryChemicals

LANXESS produces specialty chemicals for industries like agriculture, automotive, and consumer goods — think additives, intermediates, and engineering materials. Born from Bayer's 2004 spinoff, it's now Germany's chemical backbone few consumers ever hear about, yet everyone touches daily.

In Bastion Portfolios?

52W Return-41%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-8%1

Revenue Forecast

Rev CAGR (1y)-3%2

Rev CAGR (3y)+2%2

Rev CAGR (5y)+2%2

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2+40%9

EPS Growth Y+3+27%8

Quality

Margins

EBIT Margin-3%1

Net Income Margin-12%1

Free Cash Flow Margin1%3

Debt

Net Debt/EBITDA5.81

Efficiency

ROE-18%1

ROA-8%1

Earnings Stability11

GEAR+VERY WEAK2

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)na–

P/E Ratio (Forward 3y)183

P/BV0.310

EV Multiples

EV/EBITDA Fwd69

EV/EBIT Fwd1101

Yield

Free Cash Flow Yield6.9%8

Dividend Yield0.8%2

Momentum

Short term

1 month return-17%1

3 month return-14%3

YTD return-27%2

Mid term

Price vs 52wHigh59%2

1 year return-38%1

Long term

3 year return-41%1

5 year return-76%1

Risk Shield

Price Risk

Beta2.11

Volatility53%3

Free Cash Flow

Free Cash Flow Margin1%3

Free Cash Flow Yield6.9%8

Quality

ROCE-2%1

Earnings Stability11

Net Debt/EBITDA5.81

02Growth

Is it actually growing, and how fast?

LXSLANXESS Aktiengesellschaft

Revenue FY25$6.7B

GROWTH RATING↗

VERY WEAK12 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-8%1

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR+2%2

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+40%9

EPS growth, FY28E+27%8

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

After shrinking over the last 3 years, revenue is set to grow 2%/yr from here.

WEAKNESSES

Growth is the weak spot here, trailing 88% of companies worldwide.

Revenue fell 8%/yr over the last 3 years, behind 90% of companies worldwide.1/10

Revenue is set to grow 2%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that's turning around. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

LXSLANXESS Aktiengesellschaft

Total return Current−75.3%

Price return Current−78.0%

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-17%1

3-month return-14%3

YTD return-27%2

MID & LONG-TERM▾SCORE

% of 52-week high59%2

1-year return-38%1

3-year return-41%1

5-year return-76%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-41% over three years and -76% over five), behind 90% of the market.

It's down 38% over the past year, now 41% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-17%), over three months (-14%) and so far this year (-27%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on LANXESS Aktiengesellschaft. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

LXSLANXESS Aktiengesellschaft

Revenue FY25$6.7B

GROWTH RATING↗

VERY WEAK12 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-8%1

Revenue, next 1Y-3%2

Revenue, next 3Y, CAGR+2%2

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+40%9

EPS growth, FY28E+27%8

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

After shrinking over the last 3 years, revenue is set to grow 2%/yr from here.

WEAKNESSES

Growth is the weak spot here, trailing 88% of companies worldwide.

Revenue fell 8%/yr over the last 3 years, behind 90% of companies worldwide.1/10

Revenue is set to grow 2%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that's turning around. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

LXSLANXESS Aktiengesellschaft

Total return Current−75.3%

Price return Current−78.0%

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-17%1

3-month return-14%3

YTD return-27%2

MID & LONG-TERM▾SCORE

% of 52-week high59%2

1-year return-38%1

3-year return-41%1

5-year return-76%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-41% over three years and -76% over five), behind 90% of the market.

It's down 38% over the past year, now 41% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-17%), over three months (-14%) and so far this year (-27%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on LANXESS Aktiengesellschaft. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community